Evidence map›Paper›PMID 33501452›Full record

ArticlemedRxiv : the preprint server for health sciences2021

High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants.

Rafaela S Fontenele, Simona Kraberger, James Hadfield, Erin M Driver, Devin Bowes, LaRinda A Holland, Temitope O C Faleye, Sangeet Adhikari, Rahul Kumar, Rosa Inchausti and 18 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 53 citations in OpenAlex.

  1. Through the gut, down the drain.Nature reviews. Microbiology · 2021
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 7 institutions in 1 country.

Rafaela S FonteneleThe Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University, 1001 S. McAllister Ave., Tempe, Arizona, AZ 85281, USA.
Simona KrabergerThe Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University, 1001 S. McAllister Ave., Tempe, Arizona, AZ 85281, USA.
James HadfieldVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Erin M DriverBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
Devin BowesBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
LaRinda A HollandThe Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University, 1001 S. McAllister Ave., Tempe, Arizona, AZ 85281, USA.
Temitope O C FaleyeBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
Sangeet AdhikariBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
Rahul KumarBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
Rosa InchaustiStrategic Management and Diversity Office, City of Tempe, 31 E Fifth Street, Tempe, AZ 85281, USA.
Wydale K HolmesStrategic Management and Diversity Office, City of Tempe, 31 E Fifth Street, Tempe, AZ 85281, USA.
Stephanie DeitrickEnterprise GIS & Data Analytics, Information Technology, 31 E Fifth Street, City of Tempe, Tempe, AZ 85281, USA.
Philip BrownMunicipal Utilities, City of Tempe, 31 E Fifth Street, Tempe, AZ 85281, USA.
Darrell DutyTempe Fire Medical Rescue, 31 E Fifth Street, City of Tempe, Tempe, AZ 85281, USA.
Ted SmithChristina Lee Brown Envirome Institute, University of Louisville, 302 E. Muhammad Ali Blvd., Louisville, KY 40202, USA.
Aruni BhatnagarChristina Lee Brown Envirome Institute, University of Louisville, 302 E. Muhammad Ali Blvd., Louisville, KY 40202, USA.
Ray A YeagerChristina Lee Brown Envirome Institute, University of Louisville, 302 E. Muhammad Ali Blvd., Louisville, KY 40202, USA.
Rochelle H HolmChristina Lee Brown Envirome Institute, University of Louisville, 302 E. Muhammad Ali Blvd., Louisville, KY 40202, USA.
Natalia Hoogesteijn von ReitzensteinJacobs Engineering Group Inc., 1999 Bryan Street, Dallas, TX 75201, USA.
Elliott WheelerJacobs Engineering Group Inc., 1999 Bryan Street, Dallas, TX 75201, USA.
Kevin DixonJacobs Engineering Group Inc., 1999 Bryan Street, Dallas, TX 75201, USA.
Tim ConstantineJacobs Engineering Group Inc., 1999 Bryan Street, Dallas, TX 75201, USA.
Melissa A WilsonSchool of Life Sciences, Arizona State University, 427 East Tyler Mall, Tempe, Arizona, AZ 85287, USA.
Efrem S LimThe Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University, 1001 S. McAllister Ave., Tempe, Arizona, AZ 85281, USA.
Xiaofang JiangNational Library of Medicine, National Institute of Health, 8600 Rockville Pike, Bethesda, MD 20894, USA.
Rolf U HaldenBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
Matthew ScotchBiodesign Center for Environmental Health Engineering, Biodesign Institute, Arizona State University, 1001 S. McAllister Ave., Tempe, AZ 85281, USA.
Arvind VarsaniThe Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University, 1001 S. McAllister Ave., Tempe, Arizona, AZ 85281, USA.
Center for Environmental Health · USArizona State University · USJacobs (United States) · USTempe Union High School District · USUniversity of Louisville · USFred Hutch Cancer Center · USUnited States National Library of Medicine · US

Funding

Bioinformatics Framework for Wastewater-based Surveillance of Infectious DiseasesU01LM013129 · NLM · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HALDEN, ROLF U, SCOTCH, MATTHEW · 2020 to 2022
$3.3M
NLM NIH HHS U01 LM013129
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from a zoonotic spill-over event and has led to a global pandemic. The public health response has been predominantly informed by surveillance of symptomatic individuals and contact tracing, with quarantine, and other preventive measures have then been applied to mitigate further spread. Non-traditional methods of surveillance such as genomic epidemiology and wastewater-based epidemiology (WBE) have also been leveraged during this pandemic. Genomic epidemiology uses high-throughput sequencing of SARS-CoV-2 genomes to inform local and international transmission events, as well as the diversity of circulating variants. WBE uses wastewater to analyse community spread, as it is known that SARS-CoV-2 is shed through bodily excretions. Since both symptomatic and asymptomatic individuals contribute to wastewater inputs, we hypothesized that the resultant pooled sample of population-wide excreta can provide a more comprehensive picture of SARS-CoV-2 genomic diversity circulating in a community than clinical testing and sequencing alone. In this study, we analysed 91 wastewater samples from 11 states in the USA, where the majority of samples represent Maricopa County, Arizona (USA). With the objective of assessing the viral diversity at a population scale, we undertook a single-nucleotide variant (SNV) analysis on data from 52 samples with >90% SARS-CoV-2 genome coverage of sequence reads, and compared these SNVs with those detected in genomes sequenced from clinical patients. We identified 7973 SNVs, of which 5680 were novel SNVs that had not yet been identified in the global clinical-derived data as of 17th June 2020 (the day after our last wastewater sampling date). However, between 17th of June 2020 and 20th November 2020, almost half of the SNVs have since been detected in clinical-derived data. Using the combination of SNVs present in each sample, we identified the more probable lineages present in that sample and compared them to lineages observed in North America prior to our sampling dates. The wastewater-derived SARS-CoV-2 sequence data indicates there were more lineages circulating across the sampled communities than represented in the clinical-derived data. Principal coordinate analyses identified patterns in population structure based on genetic variation within the sequenced samples, with clear trends associated with increased diversity likely due to a higher number of infected individuals relative to the sampling dates. We demonstrate that genetic correlation analysis combined with SNVs analysis using wastewater sampling can provide a comprehensive snapshot of the SARS-CoV-2 genetic population structure circulating within a community, which might not be observed if relying solely on clinical cases.

Identifiers

PMID33501452
PMCPMC7836124
OpenAlexW3121611053

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.